Cartia XT (diltiazem HCl extended-release capsules, USP), Once-A-Day Dosage, 300 mg, 90-count bottles, Rx only, Manufactured by: Watson Laboratories, Inc., Corona, CA --- NDC 62037-0600-90

FDA recall notice · announced April 22, 2015 · Actavis Laboratories, Fl

Class III FDA/FSIS Class III: use is not likely to cause adverse health consequences.

The product

Cartia XT (diltiazem HCl extended-release capsules, USP), Once-A-Day Dosage, 300 mg, 90-count bottles, Rx only, Manufactured by: Watson Laboratories, Inc., Corona, CA --- NDC 62037-0600-90

Reason for recall

Presence of Foreign Substance; fine residue or dust identified as aluminum may be on exterior of the capsule shell

Notes

Distribution: Nationwide
Lot/code information: Lot # 956000M, Exp. Aug 2016; UPC 3-6203760090-6
Quantity: 2,628 bottles
Status: Terminated
Products in this recall event:
- Cartia XT (diltiazem HCl extended-release capsules, USP), Once-A-Day Dosage, 300 mg, 90-count bottles, Rx only, Manufactured by: Watson Laboratories, Inc., Corona, CA --- NDC 62037-0600-90 (D-0488-2015)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.